METHOXYFLURANE or Virtual Reality Headset vs Standard Analgesic Management for the Reduction of Anterior Shoulder Dislocation (HYPNOLUX)
Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE NICE · Apr 18, 2023
Trial Information
Current as of August 27, 2025
Recruiting
Keywords
ClinConnect Summary
The clinical trial titled "HYPNOLUX" is investigating two new methods for easing pain during the treatment of anterior shoulder dislocation, a common issue in emergency medicine. The trial compares the use of methoxyflurane, a fast-acting pain relief option, and virtual reality headsets, against the standard pain management techniques. The goal is to see if these methods can help reduce pain more effectively and improve the success of the treatment while potentially shortening the time patients spend in the emergency department.
To participate in this trial, individuals aged 65 and older who are experiencing an anterior shoulder dislocation may be eligible. However, certain criteria must be met, such as not having any recent shoulder surgeries or complications that could interfere with the study. Participants can expect to either receive methoxyflurane, use a virtual reality headset, or get standard pain management during their treatment. Importantly, this trial may help find better ways to manage pain during shoulder dislocation procedures, potentially reducing the need for heavier sedation.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Pregnant and/or breastfeeding women and women of childbearing age who do not have effective contraception (hormonal, mechanical or surgical).
- • Patients with difficulties in understanding or using the devices studied.
- • Patients with a contraindication to the use of one of the studied devices.
- • Patients with a history of relevant shoulder surgery
- • Presence of other associated trauma,
- • Previous inclusion in the same study
- Exclusion Criteria:
- • Withdrawal of voluntary informed consent from the patient
- • Violation of protocol
- • Presence of a fracture associated with the dislocation (excluding Malgaigne's notches)
- • Posterior, inferior or erecta dislocation
- • Presence of initial vascular and nerve complications
- • Any indication for surgical management
About Centre Hospitalier Universitaire De Nice
The Centre Hospitalier Universitaire (CHU) de Nice is a leading academic medical center located in Nice, France, dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, CHU de Nice is committed to enhancing patient care by conducting rigorous studies that explore new therapies and treatment modalities across various medical disciplines. With a focus on collaboration, the center integrates cutting-edge technology and interdisciplinary expertise to ensure the highest standards of research integrity and patient safety. CHU de Nice plays a vital role in the development of evidence-based medicine, contributing significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nice, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported